Personally, I'd like to see more focus on Bioseparations. It seems like it is an industry primed to be disrupted.. From the 2013 annual report:
Protein and protein drug manufacturing $3-5B market. Vaccine manufacturing $620M market in 2015
M&G capable of achieving magnetic separation that is both technically superior and economical. Current approach is chromatography which is both time consuming and expensive. I admit I don't know enough about this but it was highlighted last year but it has the potential of bringing in very long term sustainable revenue streams to the company.
Growth Strategies, page-2
Add ADO (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.1¢ |
Change
-0.001(4.55%) |
Mkt cap ! $52.28M | |||
| Open | High | Low | Value | Volume |
| 2.1¢ | 2.1¢ | 2.1¢ | $28.14K | 1.340M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 579636 | 2.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 628168 | 6 |
View Market Depth
| Last trade - 15.24pm 08/10/2024 (20 minute delay) ? |
| ADO (ASX) Chart |